logo
episode-header-image
Jul 2022
22m 7s

A Conversation With Dr Kirsten Bibbins-D...

JAMA NETWORK
About this episode

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science.

Related Content:

Up next
Sep 22
Targeting MASLD and MASH in the US Hispanic/Latino Population
Interview with Sammy Saab, MD, MPH, author of Targeting MASLD and MASH in the US Hispanic/Latino Population: A Review. Hosted by Eve Rittenberg, MD. Related Content: Targeting MASLD and MASH in the US Hispanic/Latino Population 
12m 49s
Sep 2
Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections
Interview with Robert Bals, MD, PhD, author of Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial, and Dan H. Barouch, MD, PhD, author of A Novel Approach for Preventing Respiratory Virus Infections. Hosted by Eve Rittenberg, MD. R ... Show More
11m 44s
Aug 25
Nonhormonal Treatment of Menopausal Vasomotor Symptoms
Interview with Alison J. Huang, MD, MAS, and Stephanie Faubion, MD, MBA, authors of Nonhormonal Treatment of Menopausal Vasomotor Symptoms. Hosted by Eve Rittenberg, MD. Related Content: Nonhormonal Treatment of Menopausal Vasomotor Symptoms 
17m 20s
Recommended Episodes
Jan 2025
Ophthalmic Complications Associated With Semaglutide and Tirzepatide
Interview with Bradley J. Katz, MD, PhD, author of Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide. Hosted by Neil Bressler, MD. Related Content: Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatid ... Show More
17m 17s
May 2024
Episode 902: Liver Failure and Cirrhosis
Contributor: Travis Barlock MD Educational Pearls: How do you differentiate between compensated and decompensated cirrhosis? Use the acronym VIBE to look for signs of being decompensated. V-Volume Cirrhosis can cause volume overload through a variety of mechanisms such as by incr ... Show More
3m 13s
Jun 2022
388. Liver Series - Liver Cirrhosis
By the end of this episode you will be able to: Describe the anatomy and physiology of the liver Outline the pathophysiology and common symptoms of liver failure Explain how to assess and treat a patient with cirrhosis 
36m 24s
Sep 17
NEJM This Week — September 18, 2025
Featuring articles on PI3K-altered colorectal cancer, type 2 diabetes, oral semaglutide, and proportional-assist ventilation; a review article on tumor lysis syndrome; a case report of a girl with chest pain and bone and liver lesions; and Perspectives on integrating pharmacother ... Show More
22m 12s
Apr 2017
EKU2017.1: Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) presents as a disease spectrum. Fatty change is a common and frequently benign condition, present in 20-30% of the population and up to 90% of the morbidly obese. This Essential Knowledge Update (EKU2017.1) podcast explores the NICE guide ... Show More
11m 32s
Apr 2024
Outcomes and Complications after IOL Exchange
An analysis of the IRIS® Registry shows IOL exchanges are increasing over time with vision improving 60% of the time, but worse visual outcomes associated with greater age, worse baseline vision, Black race, Hispanic ethnicity, Medicaid insurance, smoking, and concurrent vitrecto ... Show More
35m 19s
Aug 2024
Cirrhosis of the Liver and Cognitive Impairment
Most SLPs we know can count on one hand (…or one finger!?) the number of times they learned about the liver in grad school. But when it comes to our role in cognitive-communication disorders, liver disease can be a main cause — and something you absolutely should be familiar with ... Show More
7m 17s
Nov 2024
#900 The FASTEST Way To Fix Fatty Liver Naturally - 6 Common Symptoms with Ben Azadi
Fatty liver disease, encompassing both non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), is a prevalent condition in the United States. NAFLD affects approximately 24% of U.S. adults, translating to about 80 million individuals. Within this group, a sub ... Show More
25m 33s
Jul 2024
Preventing and Reversing Fatty Liver Disease | 011
Kristin Kirkpatrick, MS, RDN, renowned dietitian from the Cleveland Clinic and author of Skinny Liver and Regenerative Health explains why the liver is critical to health, and how Non-Alcoholic Fatty Liver Disease is a silent killer that has become an epidemic.  With an estimated ... Show More
1h 4m
Jul 2024
Heat-Related Illness and Athletes
Exertional heat illness at its extreme may cause heat stroke and altered mental status (confusion, delirium, stupor, or unconsciousness), which can result in organ failure and death. Author Francis G. O’Connor, MD, MPH, discusses heat-related illness in athletes, including risk f ... Show More
16m 8s